Addus HomeCare’s (ADUS) Outperform Rating Reiterated at Royal Bank of Canada

Royal Bank of Canada reiterated their outperform rating on shares of Addus HomeCare (NASDAQ:ADUS) in a research report report published on Thursday morning,Benzinga reports. They currently have a $136.00 price objective on the stock.

ADUS has been the subject of several other reports. Macquarie restated an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. TD Cowen upped their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Stephens lifted their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. KeyCorp started coverage on Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target for the company. Finally, Oppenheimer raised their price objective on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $131.63.

Addus HomeCare Price Performance

NASDAQ:ADUS opened at $119.78 on Thursday. The business’s 50-day moving average is $128.99 and its two-hundred day moving average is $122.42. The firm has a market capitalization of $2.17 billion, a PE ratio of 27.41, a price-to-earnings-growth ratio of 2.15 and a beta of 1.04. Addus HomeCare has a 12 month low of $85.43 and a 12 month high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating the consensus estimate of $1.28 by $0.02. The business had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company’s revenue was up 7.1% on a year-over-year basis. During the same period last year, the business posted $1.03 EPS. Equities analysts anticipate that Addus HomeCare will post 4.58 EPS for the current year.

Insider Buying and Selling

In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. This trade represents a 75.23 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total value of $65,015.00. Following the transaction, the director now owns 3,866 shares of the company’s stock, valued at approximately $502,695.98. The trade was a 11.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 22,917 shares of company stock worth $3,050,082 over the last ninety days. 4.60% of the stock is owned by insiders.

Hedge Funds Weigh In On Addus HomeCare

Hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in Addus HomeCare by 1.5% during the 1st quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock valued at $131,910,000 after purchasing an additional 19,027 shares during the period. Wasatch Advisors LP boosted its position in shares of Addus HomeCare by 11.8% during the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock worth $138,782,000 after buying an additional 110,010 shares during the period. Point72 Asset Management L.P. grew its holdings in Addus HomeCare by 73.4% in the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after buying an additional 315,602 shares in the last quarter. Dimensional Fund Advisors LP increased its position in Addus HomeCare by 0.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock valued at $82,930,000 after acquiring an additional 5,421 shares during the period. Finally, State Street Corp raised its stake in Addus HomeCare by 4.4% during the 3rd quarter. State Street Corp now owns 663,610 shares of the company’s stock valued at $88,280,000 after acquiring an additional 27,990 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.